AXER-204

· ReNetX Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AXER-204, covering 2023-08-22 to 2023-08-22. Get the full timeline:

Most recent: Clinical Trial Update: AXER-204 in Participants With Chronic Spinal Cord Injury [Phase 1, Phase 2]